Liposomal mitoxantrone combo before stem cell transplant for lymphoma
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This trial tests a combination of four chemotherapy drugs (mitoxantrone liposome, bendamustine, etoposide, and cytarabine) given before a stem cell transplant for people with lymphoma. The goal is to prepare the body for the transplant and improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of lymphoma (non-Hodgkin or Hodgkin) confirmed by a biopsy.
- You are between 18 and 75 years old.
- You are scheduled to have a stem cell transplant using your own cells.
- Your cancer has either not improved enough after first treatment, come back, or is responding to chemotherapy.
- Your organs (heart, lungs, liver, kidneys, bone marrow) are working well enough for the treatment.
- You have enough stem cells already collected for the transplant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a chemotherapy combination (liposome mitoxantrone plus busulfan and cyclophosphamide) given before a stem cell transplant to treat acute myeloid leukemia (AML) that is either at intermediate or high risk, or has signs of remaining leukemia cells (persistent MRD). It aims to improve transplant success for patients who still have detectable disease.
This study tests a modified chemotherapy “conditioning” plan before an autologous stem cell transplant for people with non-Hodgkin lymphoma. It aims to improve how patients tolerate and recover from the transplant process.
This trial tests a liposomal form of mitoxantrone combined with other drugs for people with aggressive multiple myeloma (high-risk or spread outside the bone). The goal is to see if this approach helps control the cancer better.
This trial tests a new combination of drugs (mitoxantrone liposome plus others) for people with AML that has returned or hasn't responded to treatment. The goal is to see if the combination is safe and effective.
This trial studies a specific type of radiation (helical tomotherapy) in people with multiple myeloma who are planning an autologous stem cell transplant. It may help the study team understand how safe and effective this approach is when used during transplant preparation.
This trial tests a combination of drugs (thiotepa, cyclophosphamide, clarithromycin, and cytarabine) before a stem cell transplant. It is for people with certain types of blood cancer who have responded well to earlier treatment.
Hear when a new Lymphoma Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.